Carole Huntsman, Chief Commercial Officer at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 910 shares at $494.59 ($449K) on 2026-01-26, disclosed to the SEC on 2026-01-26.
Scheduled sale ($449k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $492.42 | 340 | $167K | 37.3% |
| 2 | $494.59 | 570 | $282K | 62.7% |
| Total | $493.78 avg | 910 | $449K | 100% |
| Filing → |
| MDGL | SELL | 2025-03-05 | $727K | — | Filing → |
| MDGL | SELL | 2025-01-27 | $233K | — | Filing → |
| MDGL | SELL | 2024-11-22 | $436K | — | Filing → |